Convalescent plasma treatment of critically ill intensive care COVID‐19 patients

BACKGROUND: Infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) may be life‐threatening, and specific antiviral drugs are currently not available. However, first studies indicated that convalescent plasma treatment might improve the clinical outcome of coronavirus disease 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindemann, Monika, Lenz, Veronika, Knop, Dietmar, Klump, Hannes, Alt, Mira, Aufderhorst, Ulrich W., Schipper, Leonie, Schwarzkopf, Sina, Meller, Lara, Steckel, Nina, Koldehoff, Michael, Heinold, Andreas, Heinemann, Falko M., Fischer, Johannes, Hutschenreuter, Gabriele, Knabbe, Cornelius, Dolff, Sebastian, Brenner, Thorsten, Dittmer, Ulf, Witzke, Oliver, Herbstreit, Frank, Horn, Peter A., Krawczyk, Adalbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Transfusion Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251157/
https://www.ncbi.nlm.nih.gov/pubmed/33784412
http://dx.doi.org/10.1111/trf.16392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251157/
https://www.ncbi.nlm.nih.gov/pubmed/33784412
http://dx.doi.org/10.1111/trf.16392

Ejemplares similares